Efficacy of Pemetrexed or Pemetrexed Plus Cisplatin/Carboplatin in Pretreated Patients with Advanced Non–Small-Cell Lung Cancer

Journal Title: International Journal of Current Research and Review - Year 2018, Vol 10, Issue 7

Abstract

Introduction: In this study, the efficacy and safety of pemetrexed alone and platinum-pemetrexed combination chemotherapy were evaluated in patients who have demonstrated progression after the first-line treatments in advanced non-small cell lung cancer (NSCLC). Material and Method: 263 patients, who were diagnosed NSCLC in years 2008 - 2014, were assessed retrospectively in single center. Patients were given pemetrexed 500 mg/m2 , and the ones receiving combined treatment were given pemetrexed 500 mg/ m2 and cisplatin 75 mg/m2 or carboplatin area under the curve 5 according to the Calvert formula (AUC 5 ) once in every 21 days. Results: One hundred ninety (72%) of the patients had received pemetrexed, seventy three (28%) of the patients had received platinum- pemetrexed. Median PFS (progression-free survival) was 2 months (95% CI, 1. 6 - 2.4 ) for pemetrexed arm versus 4 months (95% CI, 2.6 to 5.3 ) for platinum- pemetrexed arm (p=0.001). The HR ( hazard ration) for disease progression was 0.45 (95% CI, 0.25 to 0.65) in favor of the combination arm (p=0.001). Median OS (overall survival) was 7 months (95% CI, 5.9 - 8 ) for pemetrexed arm versus 10 months (95% CI, 8 to 11.9 ) platinum-pemetrexed arm, respectively (p=0.001). The 1-year survival rate was 24% and 42% for pemetrexed arm and combination arm, respectively. Toxicities in both arm was manageable. Conclusion: Our study has shown that adding platinum compound to second-line pemetrexed chemotherapy significantly increases ORR (overall response rate), PFS and OS in patients with advanced NSCLC after having received first-line platinumbased chemotherapy.

Authors and Affiliations

Nurgul Yasar

Keywords

Related Articles

Evaluation of Scientific and Ethical Status of Drug Promotional Literatures (DPLs) for Ethical Medicinal Drug Promotion

Background: The study was aimed to evaluate the scientific and ethical status of Drug Promotional Literatures (DPLs) using World Health Organization (WHO) guidelines for ethical medicinal drug promotion. This would in tu...

Enhanced Energy Efficient Virtual Machine Placement Policy for Load Balancing in Cloud Environment

Cloud computing is an emerging computing technology that uses the Internet and central remote services to maintain data and application which are provisioned on-demand and on pay-as-you-go basis. Wide adaptation of Cloud...

Prevalence and Factors Influencing Depression in Patients with Stroke Attending a Tertiary Care Teaching Hospital, a Cross Sectional Study

Background: Stroke is a major public health problem contributing to significant morbidity and mortality across the globe. In spite of many reviews documenting a strong association between stroke and depression, it is the...

Effects of Electromagnetic Radiation Emitted from Mobile Phones on Different Physiological Systems and Possible Remedies

Aim: In this paper, we aim to provide a review of some of the studies which investigated the possible negative biological effects of mobile phone radiation on different mammalian systems. This review will provide answers...

Body Mass Index, Blood Pressure and Lipid profile in type 2 diabetes-Review

Diabetes mellitus type II (formerly noninsulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes) is a metabolic disorder that is characterized by hyperglycemia (high blood sugar) in the context of insulin resi...

Download PDF file
  • EP ID EP542398
  • DOI 10.7324/IJCRR.2018.1075
  • Views 93
  • Downloads 0

How To Cite

Nurgul Yasar (2018). Efficacy of Pemetrexed or Pemetrexed Plus Cisplatin/Carboplatin in Pretreated Patients with Advanced Non–Small-Cell Lung Cancer. International Journal of Current Research and Review, 10(7), 22-27. https://europub.co.uk/articles/-A-542398